A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MT / mutation

[Related PubMed/MEDLINE]
Total Number of Papers: 21
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MT  (>> Co-occurring Abbreviation)
Long Form:   mutation
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Epidermal growth factor receptor mutation subtype has differential effects on adjuvant chemotherapy for resected adenocarcinoma pathological stages II-III. 19 del, 21L858R, DFS, EGFR, OS, PBAC, WT
2019 Non-V600E BRAF mutations and EGFR signaling pathway in colorectal cancer. CRC, EGFR, PIK3CA
2018 Grade II and III Oligodendroglioma and Astrocytoma. ---
2018 Influence of TP53 Mutation on Survival in Patients With Advanced EGFR-Mutant Non-Small-Cell Lung Cancer. EGFR, NSCLC, OS
2018 Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial. DC, DCV, GBM, GSC, OS, PFS, TERT
2016 Biomarkers for immune therapy in colorectal cancer: mismatch-repair deficiency and others. CRC, MMR
2015 Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications. AJCC, IHC, PEAT
2015 Rapid Molecular Detection of Multidrug-Resistant Tuberculosis by PCR-Nucleic Acid Lateral Flow Immunoassay. LOD, MDR-TB, Mtb, NALF, WT
2015 Specific in situ hepatitis B viral double mutation (HBVDM) detection in urine with 60 copies ml(-1) analytical sensitivity in a background of 250-fold wild type without DNA isolation and amplification. FRMs, HBVDM, nt, pDNA, PEPS, WT
10  2015 Survival outcome according to KRAS mutation status in newly diagnosed patients with stage IV non-small cell lung cancer treated with platinum doublet chemotherapy. mo, NSCLC
11  2014 CAMKIIgamma, HSP70 and HSP90 transcripts are differentially expressed in chronic myeloid leukemia cells from patients with resistant mutated disease. CML, qPCR, TKI
12  2014 Significance of KRAS mutation in patients receiving mFOLFOX6 with or without bevacizumab for metastatic colorectal cancer. mFOLFOX6, OS, PFS, RR, WT
13  2012 Psychiatric symptoms of patients with primary mitochondrial DNA disorders. BDI-SF, GSI, HAQ-DI, HDRS, HN, PMP22, SCL-90-R
14  2010 KRAS status and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFOX chemotherapy. CRC, PFS, RPCI, RR, WT
15  2010 p53 Mutation status predicts pathological response to chemoradiotherapy in locally advanced esophageal cancer. CRT, ESCC, IHC, pCR, PCR-SSCP
16  2009 Fibroblast growth factor receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C signaling. FGFR2, MSCs, PKC, WT
17  2008 Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. cyt b, ROS
18  2008 Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels. CP, HBV, HCC, WT
19  2003 Overexpression of nicastrin increases Abeta production. APP, PS, PS, WT
20  2000 Familial growth hormone deficiency with mutated GHRH receptor gene: clinical and hormonal findings in homozygous and heterozygous individuals from Itabaianinha. FGHD, GHRH-R, IGFBP-3, SDS, WT
21  1998 Sensitivity to Fas-mediated apoptosis in pediatric acute lymphoblastic leukemia is associated with a mutant p53 phenotype and absence of Bcl-2 expression. ALL, BCP, MESF, PARP, WT